European Union - English - EMA (European Medicines Agency)

astrazeneca ab - roflumilast - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - daxas is indicated for maintenance treatment of severe chronic obstructive pulmonary disease (copd) (fev1 post-bronchodilator less than 50% predicted) associated with chronic bronchitis in adult patients with a history of frequent exacerbations as add-on to bronchodilator treatment.,

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

clarithromycin 250mg

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

clarithromycin 500mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

opsonin pharma limited - clarithromycin - powder for suspension - 250 mg/5 ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

opsonin pharma limited - clarithromycin - tablet - 250 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

opsonin pharma limited - clarithromycin - powder for suspension - 125 mg/5 ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

opsonin pharma limited - clarithromycin - tablet - 500 mg